AHA Coding Clinic® for HCPCS - 2017 Quarter 2; For Your Information
New HCPCS codes
The table below contains a listing of new HCPCS codes that will be effective for reporting on or after July 1, 2017. Please note, HCPCS code C9487 , Ustekinumab, for intravenous injection, 1 mg, which became effective for reporting on April 1, 2017, will be deleted effective June 30, 2017. The new and deleted HCPCS codes are listed below. HCPCS Code Long Descriptor Effective Date Termination Date C9487 Ustekinumab, for intravenous injection, 1 mg 4/1/2017 6/30/2017 C9489 Injection, nusinersen, 0.1 mg 7/1/2017 C9490 Injection, bezloloxtoxumab, 10 mg 7/1/2017 C9745 Nasal endoscopy, surgical; balloon dilation of Eustachian tube 7/1/2017...
Subscribe or sign in to view the full article.
Article Overview
This article presents a table of HCPCS code updates effective in mid-2017. It is useful for coding, billing, and revenue cycle staff who need to track newly added HCPCS items and a deleted code, along with the applicable effective and termination dates.
Why This Topic Matters
Keeping current with HCPCS updates helps organizations maintain accurate claim reporting and avoid using codes outside their valid date ranges. This notice supports awareness of code-set changes that may affect charge capture and reimbursement workflows.
What You Will Learn
- Which HCPCS codes were newly added for the stated effective date period.
- Which HCPCS code was scheduled for deletion and its associated date range.
- How the article organizes HCPCS update information in tabular form.
- The general scope of the mid-2017 HCPCS changes covered by the notice.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle personnel
- Compliance staff
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com